Published in Case Rep Cardiol on August 05, 2014
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr (2006) 2.63
Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol (1990) 1.94
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr (2008) 1.63
Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation (2005) 1.60
Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int (2001) 1.52
Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series. J Rheumatol (2012) 1.20
Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics (2009) 1.17
Case-control study of giant coronary aneurysms due to Kawasaki disease. Pediatr Int (2003) 1.04
The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. J Cardiol (2008) 1.01
Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study. Pediatr Cardiol (2012) 0.89
Therapeutic uses of intravenous immunoglobulin (IVIG) in children. Pediatr Rev (1995) 0.85
Association between adipokines and coronary artery lesions in children with Kawasaki Disease. J Korean Med Sci (2014) 0.75